Phillip Buckhaults to Antineoplastic Agents
This is a "connection" page, showing publications Phillip Buckhaults has written about Antineoplastic Agents.
Connection Strength
0.217
-
Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020 05 15; 11(1):2416.
Score: 0.101
-
Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy. Cancer Res. 2019 05 01; 79(9):2392-2403.
Score: 0.093
-
Biochemical and Epigenetic Insights into L-2-Hydroxyglutarate, a Potential Therapeutic Target in Renal Cancer. Clin Cancer Res. 2018 12 15; 24(24):6433-6446.
Score: 0.022